Biotechnology, nano-tech and genetics are on the forefront of medical innovation. RNAi technology has made extensive strides in the development of the Covid-vaccines. Genetics improves personal and public health, contributing to disease diagnosis, prevention, and treatment and informing reproductive decisions. We see great potential for niche technologies in this field and act as early investors and expansion managers.
